[{"address1": "11 Commerce Drive", "address2": "First Floor", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "908 967 6677", "website": "https://citiuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leonard L. Mazur", "age": 79, "title": "Co-Founder, CEO, Chairman & Secretary", "yearBorn": 1945, "fiscalYear": 2024, "totalPay": 688750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Myron Z. Holubiak", "age": 77, "title": "Co-Founder & Executive Vice Chairman", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 652500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jaime  Bartushak", "age": 56, "title": "Chief Business Officer & CFO", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 589026, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gary F. Talarico", "age": 69, "title": "Executive Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ilanit  Allen", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Lader Ph.D.", "title": "Senior VP and Head of Clinical Operations & Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Myron S. Czuczman M.D.", "age": 64, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 571375, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dhananjay G. Wadekar", "age": 70, "title": "Senior Vice President of Business Strategy", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kelly  Creighton Ph.D.", "title": "Executive Vice President of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nikolas  Burlew", "title": "Executive Vice President of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.28, "open": 1.31, "dayLow": 1.225, "dayHigh": 1.33, "regularMarketPreviousClose": 1.28, "regularMarketOpen": 1.31, "regularMarketDayLow": 1.225, "regularMarketDayHigh": 1.33, "payoutRatio": 0.0, "beta": 1.408, "forwardPE": 6.4736843, "volume": 519970, "regularMarketVolume": 519970, "averageVolume": 468240, "averageVolume10days": 610610, "averageDailyVolume10Day": 610610, "bid": 1.19, "ask": 1.28, "bidSize": 4, "askSize": 4, "marketCap": 20924996, "fiftyTwoWeekLow": 0.65, "fiftyTwoWeekHigh": 12.85, "allTimeHigh": 937.5, "allTimeLow": 0.65, "fiftyDayAverage": 1.26, "twoHundredDayAverage": 1.605735, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 19219900, "profitMargins": 0.0, "floatShares": 16519348, "sharesOutstanding": 17012191, "sharesShort": 978825, "sharesShortPriorMonth": 795318, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.0575, "heldPercentInsiders": 0.028970001, "heldPercentInstitutions": 0.05459, "shortRatio": 3.47, "shortPercentOfFloat": 0.059299998, "impliedSharesOutstanding": 18534682, "bookValue": 4.495, "priceToBook": 0.27363738, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -40990540, "trailingEps": -4.87, "forwardEps": 0.19, "lastSplitFactor": "1:25", "lastSplitDate": 1732579200, "enterpriseToEbitda": -0.467, "52WeekChange": -0.86179775, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 1.23, "targetHighPrice": 6.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 6089126, "totalCashPerShare": 0.358, "ebitda": -41137704, "totalDebt": 1881651, "quickRatio": 0.117, "currentRatio": 0.475, "debtToEquity": 2.785, "returnOnAssets": -0.22879, "returnOnEquity": -0.54696, "freeCashflow": 18358088, "operatingCashflow": -20584636, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CTXR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Citius Pharmaceuticals, Inc.", "longName": "Citius Pharmaceuticals, Inc.", "exchange": "NCM", "messageBoardId": "finmb_272471835", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1760139909, "regularMarketTime": 1760126402, "marketState": "CLOSED", "averageDailyVolume3Month": 468240, "fiftyTwoWeekLowChange": 0.58000004, "fiftyTwoWeekLowChangePercent": 0.8923078, "fiftyTwoWeekRange": "0.65 - 12.85", "fiftyTwoWeekHighChange": -11.620001, "fiftyTwoWeekHighChangePercent": -0.9042802, "fiftyTwoWeekChangePercent": -86.17977, "dividendDate": 1496966400, "earningsTimestampStart": 1766779200, "earningsTimestampEnd": 1766779200, "isEarningsDateEstimate": true, "regularMarketChangePercent": -3.90625, "regularMarketPrice": 1.23, "epsTrailingTwelveMonths": -4.87, "epsForward": 0.19, "epsCurrentYear": -2.08, "priceEpsCurrentYear": -0.5913462, "fiftyDayAverageChange": -0.029999971, "fiftyDayAverageChangePercent": -0.023809502, "twoHundredDayAverageChange": -0.37573493, "twoHundredDayAverageChangePercent": -0.2339956, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1412256600000, "postMarketChangePercent": -0.813007, "postMarketPrice": 1.22, "postMarketChange": -0.00999999, "regularMarketChange": -0.05, "regularMarketDayRange": "1.225 - 1.33", "fullExchangeName": "NasdaqCM", "displayName": "Citius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]